Prospective Study on Association of Prostatic Calcifications with Clinical Symptoms and Results of Treatment in Men with type III prostatitis

QR Code

Prospective Study on Association of Prostatic Calcifications with Clinical Symptoms and Results of Treatment in Men with type III prostatitis

Abstract The purpose is to investigate the clinical significance of prostatic calculi in patients with chronic prostatitis and to discuss the possible treatment.The data from 277 young males with CP/CPPS were analyzed prospectively. Symptom severity was measured using the National Institutes of Heal...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Xiang Fei, Wei Jin, Shengyu Hua, Yan Song
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/5ef1c64c88854880875bcbe870d03dd1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
par: Seokhwan Bang, et autres
Publié: (2021)

Evaluation of ‘Visual prostate symptom score’ in men with benign enlargement of prostate in a tertiary care center in midwestern Nepal
par: Dipesh Kumar Gupta
Publié: (2017)

Correlation of Detrusor Wall Thickness with International Prostate Symptom Score: A Cross-sectional Study of Nigerian Men with Prostate-Related Diseases
par: OBASI AUGUSTINE ULEBE, et autres
Publié: (2021)

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
par: D Gnyawali, et autres
Publié: (2016)

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making
par: Nnabugwu II, et autres
Publié: (2014)

What men want: Results from a national survey on decision making for prostate cancer treatment and research participation
par: Nancy P. Mendenhall, et autres
Publié: (2021)

Change in storage symptoms after transurethral resection of prostate: a prospective observational study
par: BR Luitel, et autres
Publié: (2016)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
par: Shih-Ting Chiu, et autres
Publié: (2021)

Mortality following hip fracture in men with prostate cancer.
par: Mieke Van Hemelrijck, et autres
Publié: (2013)

Transperineal prostate biopsy identifies locations of clinically significant prostate cancer in men considering focal therapy with PI‐RADS 3–5 regions of interest
par: Nelson Stone, et autres
Publié: (2021)

Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer
par: Paavo Raittinen, et autres
Publié: (2020)

Relationship between serum total testosterone and prostate volume in aging men
par: Bo-Wen Xia, et autres
Publié: (2021)

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?
par: William John Yaxley, et autres
Publié: (2021)

Lower urinary tract symptoms (LUTS) as a risk factor for depressive symptoms in elderly men: results from a large prospective study in Southern Chinese men.
par: Roger Y Chung, et autres
Publié: (2013)

Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria
par: Nnabugwu II, et autres
Publié: (2016)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
par: Grzesiak K, et autres
Publié: (2018)

Prostate cancer in multi‐ethnic Asian men: Real‐world experience in the Malaysia Prostate Cancer (M‐CaP) Study
par: Jasmine Lim, et autres
Publié: (2021)

Prostate-specific antigen in men from the municipality of Paipa, Boyacá 2016
par: Angela Liliana Monroy Díaz, et autres
Publié: (2018)

Outcomes of prostate cancer screening among men using antidiabetic medication
par: A. Vettenranta, et autres
Publié: (2021)

Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
par: Jabril R. Johnson, et autres
Publié: (2021)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
par: Kristin A. Plichta, et autres
Publié: (2021)

Critical appraisal of the Spanner&trade; prostatic stent in the treatment of prostatic obstruction
par: Patrick McKenzie, et autres
Publié: (2011)

Prostate cancer and prostatic diseases
Publié: (1997)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
par: Julian O. Kim, et autres
Publié: (2021)

Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres
par: Carla Lopes de Castro, et autres
Publié: (2021)

The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer.
par: Song Zheng, et autres
Publié: (2019)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
par: Neil McCartan, et autres
Publié: (2021)

A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia
par: Kristian Leisegang, et autres
Publié: (2022)

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
par: Zhang LT, et autres
Publié: (2015)

Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
par: Wang XY, et autres
Publié: (2016)

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer.
par: Giuseppe Fallara, et autres
Publié: (2021)

Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes
par: Adam B. Weiner, et autres
Publié: (2021)

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
par: Richard Shore, et autres
Publié: (2021)

Germline variation at 8q24 and prostate cancer risk in men of European ancestry
par: Marco Matejcic, et autres
Publié: (2018)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
par: Michael A. Kiebish, et autres
Publié: (2021)

A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease
par: Andrew Bakshi, et autres
Publié: (2021)

Biomarkers for Treatment Response in Advanced Prostate Cancer
par: Samia Asif, et autres
Publié: (2021)

The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
par: Yang L, et autres
Publié: (2021)

Type of treatment, symptoms and patient satisfaction play an important role in primary care contact during prostate cancer follow-up: results from the population-based PROFILES registry
par: Barbara M. Wollersheim, et autres
Publié: (2021)

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
par: Yang PS, et autres
Publié: (2018)